Skip to content
Editorial Open access

Editorial: Mechanisms of drug resistance in cancer: overcoming barriers with novel pharmacological strategies

Oct 2026 · Frontiers in Pharmacology · Vol 17 · 0 citations · 11 references
Medicine

Abstract

the importance of clinicopathological characterization and biomarker discovery. Emerging pharmacological approaches, including EZH2 inhibition, PARP-directed combination therapies, and natural product-based therapies such as (+)-PTC, may restore therapeutic sensitivity and ultimately contribute to precision oncology and improved patient outcomes.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.